Researchers have developed a new mouse model of progressive familial intrahepatic cholestasis type 3 (PFIC3) that more closely mimics…
Articles by Steve Bryson, PhD
Clearing senescent macrophages, a type of damaged immune cell that doesn’t die off as it should, reduced inflammation and reversed…
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to pevifoscorvir sodium, Aligos Therapeutics‘ oral therapy candidate…
A genetic susceptibility to gestational diabetes mellitus (GDM), a common pregnancy complication marked by intolerance to blood sugar due to…
People with metabolic dysfunction-associated steatotic liver disease (MASLD) who drink heavily at least once a month face higher odds…
Offering jail-based hepatitis C programs that include testing, treatment, and post-release support could cut new hepatitis C virus (HCV)…
A late-stage clinical trial assessing the safety and effectiveness of Mirum Pharmaceuticals’ brelovitug for adults with chronic hepatitis…
The first participant has been dosed in a large clinical trial testing TGM-312, a novel gene-silencing therapy designed to slow…
Children with Alagille syndrome who have lower blood levels of bile acids, the main component of the digestive fluid…
In preclinical studies, AT-587, Atea Pharmaceuticals’ lead oral candidate for treating hepatitis E, showed potent antiviral activity against…